SBC Medical Group Shareholders Approve Board, Charter Changes at Annual Meeting

SBC Medical Group held its 2026 annual meeting virtually and established a quorum, with shareholders voting on seven proposals including board elections and charter amendments. All director nominees were elected, and shareholders ratified MaloneBailey LLP as the company’s independent auditor for fiscal 2026. Shareholders also approved multiple charter changes, including eliminating plurality voting for directors, removing the “for cause” director removal requirement, opting out of Delaware Section 203, and adding exculpation for officers.

SBC Medical Group NASDAQ: SBC held its 2026 annual meeting of stockholders in a virtual format, with Chairman and Chief Executive Officer Yoshiyuki Aikawa presiding over the meeting. Aikawa said the virtual format was intended to be “more inclusive” and allow the company to reach a greater number of stockholders. He was joined by current directors Yuya Yoshida, who also serves as Chief Financial Officer and Chief Operating Officer, Ken Edahiro, Mike Sayama and Fumitoshi Fujiwara. Kotaro Okamoto, head of legal, served as secretary of the meeting. Okamoto said representatives of Malone Bailey LLP, the company’s independent auditors, were present and available for appropriate questions during the question-and-answer portion. Christina Kadirov of the Career Group served as Inspector of Election.

Okamoto said the company’s board of directors had fixed May 28, 2026, as the record date for determining stockholders entitled to vote. As of that date, 102,576,943 shares of common stock were outstanding and entitled to vote at the meeting. According to Okamoto, the Inspector of Election informed the company that shares represe...